Who is sponsoring NCT04973371?

NCT04973371 is sponsored by Foundation for Professional Development (Pty) Ltd.

What drugs are being tested in NCT04973371?

Interventions in NCT04973371: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test.

What condition does NCT04973371 study?

NCT04973371 studies Tuberculosis, Pulmonary, Households.

Is NCT04973371 still recruiting?

NCT04973371 is currently completed. Last updated 22 July 2021.

Last reviewed 2021-07-22 · How we verify

NCT04973371

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acceptability and Feasibility of Home-based TB Testing

Completed NA Last updated 22 July 2021

What this trial tests

NA trial testing Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test in Tuberculosis, Pulmonary in 98 participants. Completed in 30 June 2019.

Timeline

1 July 2018

Primary endpoint
31 May 2019

30 June 2019

Quick facts

Lead sponsor	Foundation for Professional Development (Pty) Ltd
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	98
Start date	1 July 2018
Primary completion	31 May 2019
Estimated completion	30 June 2019
Sites	1 location across South Africa

Drugs / interventions tested

Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test

Conditions studied

Tuberculosis, Pulmonary — all drugs for Tuberculosis, Pulmonary →
Households — all drugs for Households →

Sponsor

Foundation for Professional Development (Pty) Ltd

Who can join

18 and older, any sex, with Tuberculosis, Pulmonary or Households. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the utility of home-based point-of-care TB testing for early diagnosis and linkage to care of household contacts of TB patients, addressing the need for active case finding and early detection of infectious TB. The investigators propose an exploratory study to 1) investigate the acceptability and feasibility of home-based TB testing of household contacts using a new portable GeneXpert point-of-care (PoC) platform, and 2) determine the potential impact of such a home-based testing program on early detection of TB disease and linkage-to-care (LTC).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Bioengineering and Clinical Translation of Human Lung and its Components.
Derman ID, Singh YP, Saini S, Nagamine M, et al · · 2023 · cited 8× · PMID 36658734 · DOI 10.1002/adbi.202200267

Verify or expand the search:

Other recruiting trials for Tuberculosis, Pulmonary

Currently open trials in the same condition.

NCT07077213 — 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients · recruiting
NCT07271225 — Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting · NA · recruiting
NCT06845618 — Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment · recruiting
NCT06253715 — Shortened Regimen for Drug-susceptible TB in Children · Phase 3 · recruiting
NCT06057519 — Pragmatic Optimized Rifampicin Trial · Phase 3 · recruiting

Other Foundation for Professional Development (Pty) Ltd trials

Trials by the same sponsor.

NCT07530406 — Performance, Acceptability, and Usability of a Novel Rapid Lateral Flow Test for Detecting Neisseria Gonorrhoeae in Preg · recruiting
NCT04446611 — Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile) · NA · completed
NCT03977181 — The Community PrEP Study to Assess the Acceptance of PrEP Delivered Through CBCT Platforms · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04973371 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Foundation for Professional Development (Pty) Ltd
Last refreshed: 22 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04973371.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing